Elgordoboy said:
MTSpace said:
There's a vendor I work with, a Taiwan, China-based company that sources out of the mainland and extends us net30 terms on non-peptide business. When a competitor of his caught wind, I got a second offer of terms. Business comes down to managing risk alongside supply & demand. Today the leverage in peptides sits entirely with the seller. Splitting that risk would be an improvement.
In business, the relationship is the whole ballgame.
So who's on the hook as guarantor? A group buy splits the risk into tiny slivers across scores or hundreds of buyers, each one chasing the cheapest possible price on a big order. You'd be asking a supplier to swallow every bit of that risk alone. I'm not claiming nobody is foolish enough, but what set of circumstances would actually push a supplier into it?
The problem has already been solved: buy from a vendor who carried the risk, made the investment, and holds stock domestically. The tradeoff is a higher price. Best of luck pulling it off.
